The global Eosinophilic Disease market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Corticosteroids Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Eosinophilic Disease include Takeda Pharmaceutical Company Limited, Ellodi Pharmaceuticals, Bristol-Myers Squibb Company, AstraZeneca, GSK plc, Regeneron Pharmaceuticals Inc, Allakos Inc, Arena Pharmaceuticals Ltd and Revolo Biotherapeutics, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Eosinophils are the variety of white infection, allergy blood cells and one of the major immune system components helps in combating various and inflammatory diseases. Eosinophils develops and mature in the bone marrow and represent upto 6% of bone marrow. If the threshold of 1500?cells/?l crosses called as eosinophil-driven diseases, which causes severe inflammatory diseases and organ damage.
This report aims to provide a comprehensive presentation of the global market for Eosinophilic Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Eosinophilic Disease. This report contains market size and forecasts of Eosinophilic Disease in global, including the following market information:
- Global Eosinophilic Disease Market Revenue, 2019-2024, 2025-2030, ($ millions)
- Global Eosinophilic Disease Market Sales, 2019-2024, 2025-2030, (K Units)
- Global top five Eosinophilic Disease companies in 2023 (%)
We surveyed the Eosinophilic Disease manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Eosinophilic Disease Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Eosinophilic Disease Market Segment Percentages, by Type, 2023 (%)
- Corticosteroids
- Monoclonal Antibodies
- Anti-cytokine Drug
- Cytotoxic Drug
Global Eosinophilic Disease Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Eosinophilic Disease Market Segment Percentages, by Application, 2023 (%)
- Eosinophilic Esophagitis
- Eosinophilic Granulomatosis with Polyangiitis
- Hyper-eosinophilic Syndrome
- Nasal Polyposis
- Other
Global Eosinophilic Disease Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Eosinophilic Disease Market Segment Percentages, By Region and Country, 2023 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Eosinophilic Disease revenues in global market, 2019-2024 (Estimated), ($ millions)
- Key companies Eosinophilic Disease revenues share in global market, 2023 (%)
- Key companies Eosinophilic Disease sales in global market, 2019-2024 (Estimated), (K Units)
- Key companies Eosinophilic Disease sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Takeda Pharmaceutical Company Limited
- Ellodi Pharmaceuticals
- Bristol-Myers Squibb Company
- AstraZeneca
- GSK plc
- Regeneron Pharmaceuticals Inc
- Allakos Inc
- Arena Pharmaceuticals Ltd
- Revolo Biotherapeutics
- DBV Technologies
- Cipla Inc
- Sun Pharmaceutical Industries Ltd
- Sanofi
Outline of Major Chapters:
Chapter 1: Introduces the definition of Eosinophilic Disease, market overview.
Chapter 2: Global Eosinophilic Disease market size in revenue and volume.
Chapter 3: Detailed analysis of Eosinophilic Disease manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Eosinophilic Disease in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Eosinophilic Disease capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
